<p>Dr. von Drygalski shares her thoughts about the importance of this research and its relevance to clinical practice.</p>

Dr. von Drygalski shares her thoughts about the importance of this research and its relevance to clinical practice.

Conclusions

The treatment of persons with hemophilia continues to evolve, with important advancements that address limitations with factor replacement such as diminished efficacy in patients with inhibitors and the burden of frequent intravenous administration. This 30-minute activity delves into the latest research presented at ISTH 2025, highlighting rebalancing agents and factor VIII mimetics. In addition to discussing details of each trial, Dr. von Drygalski shares her thoughts about its importance and relevance to clinical practice.

Share Conclusions

Sign up to save your podcasts

Conclusions

Conclusions